Icatibant
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB06196 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 73 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | C1 inhibitor deficiency | KG + DL |
| 2 | serpinopathy with toxic serpin polymerization | KG + DL |
| 3 | pseudo-von Willebrand disease | KG + DL |
| 4 | primary release disorder of platelets | KG + DL |
| 5 | immune-mediated necrotizing myopathy | KG + DL |
| 6 | antisynthetase syndrome | KG + DL |
| 7 | Glanzmann thrombasthenia | KG + DL |
| 8 | focal myositis | KG + DL |
| 9 | Scott syndrome | KG + DL |
| 10 | inflammatory myopathy with abundant macrophages | KG + DL |
| 11 | idiopathic eosinophilic myositis | KG + DL |
| 12 | Peyronie disease | KG + DL |
| 13 | pancreatitis | KG + DL |
| 14 | pernicious anemia | KG + DL |
| 15 | thrombotic thrombocytopenic purpura | KG + DL |
| 16 | inherited thrombophilia | KG + DL |
| 17 | selective IgG immunodeficiency | KG + DL |
| 18 | bleeding diathesis due to a collagen receptor defect | KG + DL |
| 19 | recurrent infections associated with rare immunoglobulin isotypes deficiency | KG + DL |
| 20 | hemorrhagic disorder due to a constitutional thrombocytopenia | KG + DL |
| 21 | dermatomyositis | KG + DL |
| 22 | familial apolipoprotein C-II deficiency | KG + DL |
| 23 | thrombocytopenic purpura | KG + DL |
| 24 | primary amyloidosis | KG + DL |
| 25 | acquired amyloid peripheral neuropathy | KG + DL |
| 26 | venous insufficiency (disease) | KG + DL |
| 27 | esophageal varices without bleeding | KG + DL |
| 28 | esophageal varices with bleeding | KG + DL |
| 29 | flood factor deficiency | KG + DL |
| 30 | symptomatic form of hemophilia in female carriers | KG + DL |
| 31 | dermis disease | KG + DL |
| 32 | varicose disease | KG + DL |
| 33 | hereditary thrombocytosis with transverse limb defect | KG + DL |
| 34 | familial thrombomodulin anomalies | KG + DL |
| 35 | nodular cutaneous amyloidosis | KG + DL |
| 36 | macular amyloidosis | KG + DL |
| 37 | amyloidosis cutis dyschromia | KG + DL |
| 38 | selective IgG subclass deficiency | KG + DL |
| 39 | posterior leukoencephalopathy syndrome | KG + DL |
| 40 | subarachnoid hemorrhage (disease) | KG + DL |
| 41 | papillomatosis | KG + DL |
| 42 | Ledderhose disease | KG + DL |
| 43 | methylcobalamin deficiency type cblG | KG + DL |
| 44 | infantile digital fibromatosis | KG + DL |
| 45 | penile fibromatosis | KG + DL |
| 46 | amyloidosis (disease) | KG + DL |
| 47 | papilloma | KG + DL |
| 48 | palmar fibromatosis | KG + DL |
| 49 | hemophilia | KG + DL |
| 50 | fetal and neonatal alloimmune thrombocytopenia | KG + DL |
(Showing top 50 of 73 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.